Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 35

1.

Interleukin-6/STAT3 Signaling is Prominent and Associated with Reduced Overall Survival in p16 Negative Oropharyngeal Squamous Cell Carcinoma.

Lesinski GB, Nannapaneni S, Griffith CC, Patel M, Chen W, Chen Z, Ahmed R, Wieland A, Shin DM, Chen ZG, Saba NF.

Head Neck Pathol. 2018 Sep 6. doi: 10.1007/s12105-018-0962-y. [Epub ahead of print]

PMID:
30191505
2.

A Correlative Analysis of PD-L1, PD-1, PD-L2, EGFR, HER2, and HER3 Expression in Oropharyngeal Squamous Cell Carcinoma.

Steuer CE, Griffith CC, Nannapaneni S, Patel MR, Liu Y, Magliocca KR, El-Deiry MW, Cohen C, Owonikoko TK, Shin DM, Chen ZG, Saba NF.

Mol Cancer Ther. 2018 Mar;17(3):710-716. doi: 10.1158/1535-7163.MCT-17-0504. Epub 2018 Feb 13.

PMID:
29440293
3.

Honokiol Radiosensitizes Squamous Cell Carcinoma of the Head and Neck by Downregulation of Survivin.

Wang X, Beitler JJ, Huang W, Chen G, Qian G, Magliocca K, Patel MR, Chen AY, Zhang J, Nannapaneni S, Kim S, Chen Z, Deng X, Saba NF, Chen ZG, Arbiser JL, Shin DM.

Clin Cancer Res. 2018 Feb 15;24(4):858-869. doi: 10.1158/1078-0432.CCR-17-0345. Epub 2017 Nov 27.

4.

Systemic Delivery of Bc12-Targeting siRNA by DNA Nanoparticles Suppresses Cancer Cell Growth.

Rahman MA, Wang P, Zhao Z, Wang D, Nannapaneni S, Zhang C, Chen Z, Griffith CC, Hurwitz SJ, Chen ZG, Ke Y, Shin DM.

Angew Chem Int Ed Engl. 2017 Dec 11;56(50):16023-16027. doi: 10.1002/anie.201709485. Epub 2017 Nov 15.

PMID:
29076273
5.

Prognostic biomarkers in patients with human immunodeficiency virus-positive disease with head and neck squamous cell carcinoma.

Zhang H, Kim S, Chen Z, Nannapaneni S, Chen AY, Moore CE, Sica G, Mosunjac M, Nguyen MLT, D'Souza G, Carey TE, Peterson LA, McHugh JB, Graham M, Komarck CM, Wolf GT, Walline HM, Bellile E, Riddell J 4th, Pai SI, Sidransky D, Westra WH, William WN Jr, Lee JJ, El-Naggar AK, Ferris RL, Seethala R, Grandis JR, Chen ZG, Saba NF, Shin DM; Head and Neck Cancer SPORE HIV supplement consortium.

Head Neck. 2017 Dec;39(12):2433-2443. doi: 10.1002/hed.24911. Epub 2017 Sep 25.

PMID:
28945296
6.

Phenformin enhances the therapeutic effect of selumetinib in KRAS-mutant non-small cell lung cancer irrespective of LKB1 status.

Zhang J, Nannapaneni S, Wang D, Liu F, Wang X, Jin R, Liu X, Rahman MA, Peng X, Qian G, Chen ZG, Wong KK, Khuri FR, Zhou W, Shin DM.

Oncotarget. 2017 Aug 1;8(35):59008-59022. doi: 10.18632/oncotarget.19779. eCollection 2017 Aug 29.

7.

Antitumor Activity of 2,9-Di-Sec-Butyl-1,10-Phenanthroline.

Wang D, Peng S, Amin AR, Rahman MA, Nannapaneni S, Liu Y, Shin DM, Saba NF, Eichler JF, Chen ZG.

PLoS One. 2016 Dec 29;11(12):e0168450. doi: 10.1371/journal.pone.0168450. eCollection 2016.

8.

Human papillomavirus oncoprotein E6 upregulates c-Met through p53 downregulation.

Qian G, Wang D, Magliocca KR, Hu Z, Nannapaneni S, Kim S, Chen Z, Sun SY, Shin DM, Saba NF, Chen ZG.

Eur J Cancer. 2016 Sep;65:21-32. doi: 10.1016/j.ejca.2016.06.006. Epub 2016 Jul 22.

9.

HER3 Targeting Sensitizes HNSCC to Cetuximab by Reducing HER3 Activity and HER2/HER3 Dimerization: Evidence from Cell Line and Patient-Derived Xenograft Models.

Wang D, Qian G, Zhang H, Magliocca KR, Nannapaneni S, Amin AR, Rossi M, Patel M, El-Deiry M, Wadsworth JT, Chen Z, Khuri FR, Shin DM, Saba NF, Chen ZG.

Clin Cancer Res. 2017 Feb 1;23(3):677-686. doi: 10.1158/1078-0432.CCR-16-0558. Epub 2016 Jun 29.

10.

Preliminary noise reduction efforts in a medical intensive care unit.

Nannapaneni S, Lee SJ, Kashiouris M, Elmer JL, Thakur LK, Nelson SB, Bowron CT, Danielson RD, Surani S, Ramar K.

Hosp Pract (1995). 2015;43(2):94-100. doi: 10.1080/21548331.2015.1015389. Epub 2015 Feb 17.

PMID:
25687293
11.

Heterotypic gap junctions at glutamatergic mixed synapses are abundant in goldfish brain.

Rash JE, Kamasawa N, Vanderpool KG, Yasumura T, O'Brien J, Nannapaneni S, Pereda AE, Nagy JI.

Neuroscience. 2015 Jan 29;285:166-93. doi: 10.1016/j.neuroscience.2014.10.057. Epub 2014 Nov 4.

12.

Assessing and predicting the likelihood of interventions during routine annual follow-up visits for management of obstructive sleep.

Nannapaneni S, Morgenthaler TI, Ramar K.

J Clin Sleep Med. 2014 Aug 15;10(8):919-24. doi: 10.5664/jcsm.3972.

13.

Combination of anti-HER3 antibody MM-121/SAR256212 and cetuximab inhibits tumor growth in preclinical models of head and neck squamous cell carcinoma.

Jiang N, Wang D, Hu Z, Shin HJ, Qian G, Rahman MA, Zhang H, Amin AR, Nannapaneni S, Wang X, Chen Z, Garcia G, MacBeath G, Shin DM, Khuri FR, Ma J, Chen ZG, Saba NF.

Mol Cancer Ther. 2014 Jul;13(7):1826-36. doi: 10.1158/1535-7163.MCT-13-1093. Epub 2014 Apr 18.

14.

Periodic limb movements during sleep and their effect on the cardiovascular system: is there a final answer?

Nannapaneni S, Ramar K.

Sleep Med. 2014 Apr;15(4):379-84. doi: 10.1016/j.sleep.2013.12.014. Epub 2014 Feb 26. Review.

PMID:
24656911
15.

Honokiol enhances paclitaxel efficacy in multi-drug resistant human cancer model through the induction of apoptosis.

Wang X, Beitler JJ, Wang H, Lee MJ, Huang W, Koenig L, Nannapaneni S, Amin AR, Bonner M, Shin HJ, Chen ZG, Arbiser JL, Shin DM.

PLoS One. 2014 Feb 25;9(2):e86369. doi: 10.1371/journal.pone.0086369. eCollection 2014.

16.

Nocturnal vocalization.

Nannapaneni S, Olson E, Ramar K.

J Clin Sleep Med. 2014 Feb 15;10(2):229-32. doi: 10.5664/jcsm.3462. No abstract available.

17.

Luteolin nanoparticle in chemoprevention: in vitro and in vivo anticancer activity.

Majumdar D, Jung KH, Zhang H, Nannapaneni S, Wang X, Amin AR, Chen Z, Chen ZG, Shin DM.

Cancer Prev Res (Phila). 2014 Jan;7(1):65-73. doi: 10.1158/1940-6207.CAPR-13-0230.

18.

Effect of obstructive sleep apnea on type 2 diabetes mellitus: A comprehensive literature review.

Nannapaneni S, Ramar K, Surani S.

World J Diabetes. 2013 Dec 15;4(6):238-44. doi: 10.4239/wjd.v4.i6.238. Review.

19.

Chemoprevention of head and neck cancer with celecoxib and erlotinib: results of a phase ib and pharmacokinetic study.

Saba NF, Hurwitz SJ, Kono SA, Yang CS, Zhao Y, Chen Z, Sica G, Müller S, Moreno-Williams R, Lewis M, Grist W, Chen AY, Moore CE, Owonikoko TK, Ramalingam S, Beitler JJ, Nannapaneni S, Shin HJ, Grandis JR, Khuri FR, Chen ZG, Shin DM.

Cancer Prev Res (Phila). 2014 Mar;7(3):283-91. doi: 10.1158/1940-6207.CAPR-13-0215. Epub 2013 Oct 3.

20.

Molecular and functional asymmetry at a vertebrate electrical synapse.

Rash JE, Curti S, Vanderpool KG, Kamasawa N, Nannapaneni S, Palacios-Prado N, Flores CE, Yasumura T, O'Brien J, Lynn BD, Bukauskas FF, Nagy JI, Pereda AE.

Neuron. 2013 Sep 4;79(5):957-69. doi: 10.1016/j.neuron.2013.06.037.

21.

RRM2 regulates Bcl-2 in head and neck and lung cancers: a potential target for cancer therapy.

Rahman MA, Amin AR, Wang D, Koenig L, Nannapaneni S, Chen Z, Wang Z, Sica G, Deng X, Chen ZG, Shin DM.

Clin Cancer Res. 2013 Jul 1;19(13):3416-28. doi: 10.1158/1078-0432.CCR-13-0073. Epub 2013 May 29.

22.

CPAP compliance study and circadian rhythm disorders.

Nannapaneni S, Ramar K.

J Clin Sleep Med. 2013 Apr 15;9(4):404-7. doi: 10.5664/jcsm.2602. No abstract available.

23.

Chemoprevention of head and neck cancer by simultaneous blocking of epidermal growth factor receptor and cyclooxygenase-2 signaling pathways: preclinical and clinical studies.

Shin DM, Zhang H, Saba NF, Chen AY, Nannapaneni S, Amin AR, Müller S, Lewis M, Sica G, Kono S, Brandes JC, Grist WJ, Moreno-Williams R, Beitler JJ, Thomas SM, Chen Z, Shin HJ, Grandis JR, Khuri FR, Chen ZG.

Clin Cancer Res. 2013 Mar 1;19(5):1244-56. doi: 10.1158/1078-0432.CCR-12-3149. Epub 2013 Feb 19.

24.

Half-and-half nail.

Chadha S, Nannapaneni S, Shetty V, Shani J.

Am J Med Sci. 2013 Dec;346(6):513. doi: 10.1097/MAJ.0b013e31826c9fc1. No abstract available.

PMID:
23138123
25.

The pivotal role of integrin β1 in metastasis of head and neck squamous cell carcinoma.

Wang D, Müller S, Amin AR, Huang D, Su L, Hu Z, Rahman MA, Nannapaneni S, Koenig L, Chen Z, Tighiouart M, Shin DM, Chen ZG.

Clin Cancer Res. 2012 Sep 1;18(17):4589-99. doi: 10.1158/1078-0432.CCR-11-3127. Epub 2012 Jul 24.

26.

Systemic delivery of siRNA nanoparticles targeting RRM2 suppresses head and neck tumor growth.

Rahman MA, Amin AR, Wang X, Zuckerman JE, Choi CH, Zhou B, Wang D, Nannapaneni S, Koenig L, Chen Z, Chen ZG, Yen Y, Davis ME, Shin DM.

J Control Release. 2012 May 10;159(3):384-92. doi: 10.1016/j.jconrel.2012.01.045. Epub 2012 Feb 8.

27.

Comparison of quantum dot technology with conventional immunohistochemistry in examining aldehyde dehydrogenase 1A1 as a potential biomarker for lymph node metastasis of head and neck cancer.

Xu J, Müller S, Nannapaneni S, Pan L, Wang Y, Peng X, Wang D, Tighiouart M, Chen Z, Saba NF, Beitler JJ, Shin DM, Chen ZG.

Eur J Cancer. 2012 Jul;48(11):1682-91. doi: 10.1016/j.ejca.2011.12.029. Epub 2012 Feb 15.

28.

Trafficking of gap junction channels at a vertebrate electrical synapse in vivo.

Flores CE, Nannapaneni S, Davidson KG, Yasumura T, Bennett MV, Rash JE, Pereda AE.

Proc Natl Acad Sci U S A. 2012 Feb 28;109(9):E573-82. doi: 10.1073/pnas.1121557109. Epub 2012 Feb 7. Erratum in: Proc Natl Acad Sci U S A. 2013 Nov 12;110(46):18735.

29.

Oxygen reduction kinetics on graphite cathodes in sediment microbial fuel cells.

Renslow R, Donovan C, Shim M, Babauta J, Nannapaneni S, Schenk J, Beyenal H.

Phys Chem Chem Phys. 2011 Dec 28;13(48):21573-84. doi: 10.1039/c1cp23200b. Epub 2011 Nov 3.

30.

A dual-targeting antibody against EGFR-VEGF for lung and head and neck cancer treatment.

Zhang H, Yun S, Batuwangala TD, Steward M, Holmes SD, Pan L, Tighiouart M, Shin HJ, Koenig L, Park W, Rycroft D, Nannapaneni S, Wang Y, Chen ZG, Shin DM.

Int J Cancer. 2012 Aug 15;131(4):956-69. doi: 10.1002/ijc.26427. Epub 2011 Nov 19.

31.

Variability of distribution of Ca(2+)/calmodulin-dependent kinase II at mixed synapses on the mauthner cell: colocalization and association with connexin 35.

Flores CE, Cachope R, Nannapaneni S, Ene S, Nairn AC, Pereda AE.

J Neurosci. 2010 Jul 14;30(28):9488-99. doi: 10.1523/JNEUROSCI.4466-09.2010.

32.

The yeast dynamin-like protein Vps1:vps1 mutations perturb the internalization and the motility of endocytic vesicles and endosomes via disorganization of the actin cytoskeleton.

Nannapaneni S, Wang D, Jain S, Schroeder B, Highfill C, Reustle L, Pittsley D, Maysent A, Moulder S, McDowell R, Kim K.

Eur J Cell Biol. 2010 Jul;89(7):499-508. doi: 10.1016/j.ejcb.2010.02.002. Epub 2010 Mar 2.

PMID:
20189679
33.

The distribution of apolipoprotein E in mouse olfactory epithelium.

Nathan BP, Nannapaneni S, Gairhe S, Nwosu I, Struble RG.

Brain Res. 2007 Mar 16;1137(1):78-83. Epub 2006 Dec 20.

34.

Elevated B-type natriuretic peptide level: use with caution in patients with multiple co-morbidities and presenting with dyspnea.

Jeevanantham V, Shrivastava R, Nannapaneni S, Khan A, Sengodan M, Nautiyal A, Navaneethan S, Hsi D.

Indian Heart J. 2007 Jan-Feb;59(1):64-8.

PMID:
19098338
35.

Educational intervention: a tool for decreasing medication errors.

Navaneethan S, Venkatesh S, Nannapaneni S, Shrivastava R.

Int J Qual Health Care. 2005 Feb;17(1):83. No abstract available.

PMID:
15668315

Supplemental Content

Loading ...
Support Center